ARCHIVES

Funding Opportunities: Career Development Award In Leukemia

This article is from The Cancer Letter archive.

Vol. 25 No. 29 | July 23, 1999

Download PDF Visit The Full Archive

Related Articles

Information Lacking On Use, Accuracy Of HER2 Tests

September 25, 2009

Amgen Announces Cochrane Findings: ESAs Increase Risk Of On-Study Death.

October 3, 2008

In Brief: Best Guess On NCI Director: Brown First Choice, Benacerraf Second; FDa On Saccharin

April 22, 1977

In Brief: Harmon Eyre Heads Medical Affairs, Research As Third Member OF ACS National Office “Troika”

April 16, 1993

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

August 26, 2011

Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA.

May 16, 2008